al-53817
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2011 (NCT01454505)
Timeline
Indications
Mechanism of action
- Ghrelin receptorINVERSE AGONIST
GHSR inverse agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- al-53817
- al-817
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02079649 | Phase 2 | Apr 1, 2014 | Alcon |
| NCT01908803 | Phase 2 | Dec 1, 2013 | Alcon |
| NCT01454505 | Phase 1 | Oct 1, 2011 | Alcon |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alcon | For profit | 3 | 3 | 2 | 2011 |
1 organizations
Page 1 / 1